SYNJARDYXR(empagliflozin and metformin hydrochloride extended-release) tablets(三十八)
lude diarrhea, nausea, vomiting, gas, stomach pain, indigestion, weakness, and headache.
These are not all the possible side effects of SYNJARDY XR. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store SYNJARDY XR?
Store SYNJARDY XR at room temperature between 68°F to 77°F (20°C to 25°C).
General information about the safe and effective use of SYNJARDY XR.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use SYNJARDY XR for a condition for which it was not prescribed. Do not give SYNJARDY XR to other people, even if they have the same symptoms that you have. It may harm them.
This Medication Guide summarizes the most important information about SYNJARDY XR. If you would like more information, talk with your doctor. You can ask your pharmacist or healthcare provider for information about SYNJARDY XR that is written for health professionals.
What are the ingredients in SYNJARDY XR?
Active Ingredients: empagliflozin and metformin hydrochloride
Inactive Ingredients: Tablet core contains: polyethylene oxide, hypromellose, and magnesium stearate. The Film Coatings and Printing Ink contain: hypromellose, titanium dioxide, polydextrose, polyethylene glycol, talc, carnauba wax, purified water, ferrosoferric oxide, propylene glycol, isopropyl alcohol, ferric oxide yellow (5 mg /1000 mg, 10 mg /1000 mg, 25 mg /1000 mg), ferric oxide red (10 mg /1000 mg), FD&C blue#2/indigo carmine aluminum lake (12.5mg/1000mg, 25mg/1000mg).
Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc.; Ridgefield, CT 06877 USA
Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc.; Ridgefield, CT 06877 USA and Eli Lilly and Company, Indianapolis, IN 46285 USA
Licensed from: Boehringer Ingelheim International GmbH, Ingelheim, Germany
Boehringer Ingelheim Pharmaceuticals, Inc. either owns or uses the Synjardy® and EMPA-REG OUTCOME® trademarks under license.
The other trademarks referenced are owned by third parties not affiliated with Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright © 2016 Boehringer Ingelheim International GmbH
ALL RIGHTS RESERVED
IT7030BL232016
For more information, go to www.synjardyxr.com, or scan the adjacent code, or call
Boehringer Ingelheim Pharmaceuticals, Inc. at 1-800-542-6257 or (TTY) 1-800-459-9906. Syjardy QR CodeCLOSE
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 0597-0280-73
DISPENSE WITH MEDICATION GUIDE
Synjardy® XR
(empagliflozin and metformin hydrochloride extended-release)
Tablets
10 mg/1000 mg
Rx only
Boehringer Ingelheim
Lilly
Each extended-release tablet contains 10 mg of empagliflozin and 1000 mg of metformin hydrochloride.
Dosage: See package insert.
Tablets must not be split, crushed, dissolved, or chewed before swallowing.
Store at 25°C (77°F); excursions permitted to 15-30°C (59°-86°F)
[see USP Controlled Room Temperature |